STOCK TITAN

Twist Bioscience (TWST) insider Leproust plans resale after option exercise

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience insider Emily M. Leproust filed to resell up to 19,952 shares of common stock, held at Fidelity Brokerage Services, with an aggregate market value of $2,495,507.42, in a transaction related to a stock option exercise dated August 12, 2026, on NASDAQ. The filing also lists prior common stock sales over the past three months, including 113,318 shares for $14,183,062.19 on August 10, 2026. The issuer reports 62,707,424 shares of common stock outstanding as a baseline figure.

Positive

  • None.

Negative

  • None.
Shares to be sold 19,952 shares Common stock to be resold related to stock option exercise on 08/12/2026
Aggregate market value of planned sale $2,495,507.42 Market value for 19,952 common shares referenced in the filing
Shares outstanding 62,707,424 shares Common stock outstanding as referenced in the filing
Largest recent sale shares 113,318 shares Common shares sold on 08/10/2026 by Emily M. Leproust
Largest recent sale value $14,183,062.19 Aggregate value of 113,318 shares sold on 08/10/2026
Prior sale example 25,017 shares Common shares sold on 05/27/2026 with aggregate value $1,633,407.46
stock option exercise financial
"Common | 08/12/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
aggregate market value financial
"Common | Fidelity Brokerage Services LLC ... | 19952 | 2495507.42"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 08/12/2026 | Stock Option Exercise"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months Emily M. Leproust"

FAQ

What does the TWST Form 144 filing by Emily M. Leproust disclose?

The filing discloses an intent to resell up to 19,952 TWST common shares following a stock option exercise on August 12, 2026. It also lists several prior stock sales over the preceding three months with corresponding share amounts and dollar values.

How many TWST shares does Emily M. Leproust plan to sell in this Form 144?

Emily M. Leproust plans to sell up to 19,952 shares of TWST common stock. These shares are associated with a stock option exercise dated August 12, 2026 and are held at Fidelity Brokerage Services LLC for potential sale on NASDAQ.

What is the reported market value of the TWST shares in the planned Form 144 sale?

The Form 144 reports an aggregate market value of $2,495,507.42 for the 19,952 TWST shares that may be sold. This figure reflects the market value tied to the planned resale, not necessarily the final proceeds from any executed transactions.

What prior TWST stock sales by Emily M. Leproust are listed in the last three months?

The filing lists multiple prior TWST sales, including 113,318 shares for $14,183,062.19 on August 10, 2026 and other trades ranging from 2,265 to 25,017 shares on various dates in May, June, and August 2026.

How many TWST common shares are reported outstanding in this Form 144?

The Form 144 reports 62,707,424 shares of TWST common stock outstanding. This number provides a baseline reference for the company’s equity, separate from the 19,952 shares that may be sold under this particular filing.

What is the nature of acquisition for the TWST shares in this Form 144?

The 19,952 TWST shares covered by the Form 144 were acquired through a stock option exercise from the issuer, with the payment described as cash on August 12, 2026, before being made available for potential resale on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature